| 5K7G: reference: Discovery and Optimisation of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88(L265P) Diffuse Large B-Cell Lymphoma., Scott JS, Degorce SL, Anjum R, Culshaw J, Davies RMD, Davies NL, Dillman KS, Dowling JE, Drew L, Ferguson AD, Groombridge SD, Halsall CT, Hudson JA, Lamont S, Lindsay NA, Marden SK, Mayo MF, Pease JE, Perkins DR, Pink JH, Robb GR, Rosen A, Shen M, McWhirter C, Wu D, J Med Chem. 2017 Nov 27. doi: 10.1021/acs.jmedchem.7b01290. PMID: 29172502 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).